IBM has raised its dividend for three decades straight, but the latest increase fits on a penny. Before counting on that income to keep pace with rising costs, retirees should understand what the streak…
Texas ranchers sitting on acreage data centers desperately need are discovering the lease deal can do something the rent check barely hints at: quietly reshape when and whether Social Security needs to start at…
Where you park a high-yield dividend stock can quietly cost you thousands in taxes every single year, and REITs and MLPs carry the steepest penalty of all for investors sitting in the wrong account.
Owners across The Villages are quietly running the full numbers on their homes and walking away stunned. The purchase price turns out to be the least expensive part of the equation.
Warren Buffett's exit from Berkshire Hathaway reignited a debate value investors have circled for years: whether one smaller insurer running the same three-engine compounding model can fill the void, and whether its recent struggles…
Palantir just posted revenue growth above 90% year-over-year with a Rule of 40 score that has Wall Street rubbing its eyes, yet the five-year model tells a far more complicated story than the bull…
Uranium mining sits at the narrow end of the funnel feeding the AI-driven reactor buildout, and three US-listed juniors are racing to fill a supply gap that utilities cannot contract their way out of.…
Both Amgen and Merck write quarterly checks and raise them every year, but only one has the portfolio depth to keep growing that payout through the next brutal round of patent expirations. The answer…
When a nursing home mails a discharge notice for nonpayment while a Medicaid application sits pending at the county office, most families assume they have no choice but to scramble for the money or…